1Leon SA,Shapiro B,Sklaroff DM,et al.Free DNA in the serum of cancer patients and the effect of therapy.Cancer Res,1977,37:646-650.
2Jahr S,Hentze H,Englisch S,et al.DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptotic and necrotic cells.Cancer Res,2001,61:1659-1665.
3Anker P,Lyautey J,Lederrey C,et al.Circulating nucleic acids in plasma or serum.Clin Chim Acta,2001,313:143-146.
4Anker P,Mulcahy H,Chen XQ,et al.Detection of circulating tumor DNA in the blood (plasma/serum) of cancer patients.Cancer Metastasis Rev,1999,18:65-73.
5Wong IH,Zhang J,Lai PB,et al.Quantitative analysis of tumorderived methylated p16INK4a sequences in plasma,serum,and blood cells of hepato cellular carcinoma patients.Clin Cancer Res,2003,9:1047-1052.
6Szymanska K,Lesi OA,Kirk GD,et al.Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia,West Africa.Int J Cancer,2004,110:374-379.
7Silva JM,Dominguez G,Garcia JM,et al.Presence of tumor DNA in plasma of breast cancer patients:clinicopathological correlations.Cancer Res,1999,59:3251-3256.
8Allan JM,Hardie LJ,Briggs JA,et al.Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer.Int J Cancer,2001,91:359-365.
9Lin JC,Chen KY,Wang WY,et al.PCR detection of circulating tumor cells in nasopharyngeal carcinoma patients with distant metastasis:effect of enzyme and sampling.Head Neck,2002,24:591-596.
10Dahse R,Utting M,Werner W,et al.TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum,plasma and urine samples.Int J Oncol,2002,20:107-115.
